Resting T cells negatively regulate osteoclast generation from peripheral blood monocytes

Bone

Volumn 33, Issue 4, 2003, Pages 711-720

  Shinoda, K ^a   Sugiyama, E ^a   Taki, H ^a   Harada, S ^a   Mino, T ^a   Maruyama, M ^a   Kobayashi, M ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Cyclosporine A; GM CSF; IFN ; Osteoclast; T cell

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; CD4 ANTIGEN; CD8 ANTIGEN; COLONY STIMULATING FACTOR 1; CYCLOSPORIN A; GAMMA INTERFERON; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE;

ARTICLE; ASSAY; CELL ACTIVITY; CELL DIFFERENTIATION; CELL INTERACTION; CELL ISOLATION; CELL LINE; CELL STIMULATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENTIN; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MONOCYTE; NORMAL HUMAN; OSTEOCLAST; PROTEIN SYNTHESIS INHIBITION; T LYMPHOCYTE;

EID: 0141750624     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00230-8     Document Type: Article

References (46)

1. Jimi E., Nakamura I., Amano H., Taguchi Y., Tsurukai T., Tamura M., et al. Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to-cell contact. Endocrinology. 137:1996;2187-2190.
2. Takahashi N., Akatsu T., Udagawa N., Sasaki T., Yamaguchi A., Moseley J.M., et al. Osteoblastic cells are involved in osteoclast formation. Endocrinology. 123:1988;2600-2602.
3. Mostov K., Werb Z. Journey across the osteoclast. Science. 276:1997;219-220.
4. Sharrock W.J. Bone and the hematopoietic and immune systems: a report of the proceedings of a scientific workshop. J Bone Miner Res. 13:1998;537-543.
5. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Annu Rev Immunol. 20:2002;795-823.
6. Abu-Amer Y. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB. J Clin Invest. 107:2001;1375-1385.
7. Bendixen A.C., Shevde N.K., Dienger K.M., Willson T.M., Funk C.D., Pike J.W. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ 1. Proc Natl Acad Sci USA. 98:2001;2443-2448.
8. Hong M.H., Williams H., Jin C.H., Pike J.W. The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins. J Bone Miner Res. 15:2000;911-918.
9. Kobayashi K., Takahashi N., Jimi E., Udagawa N., Takami M., Kotake S., et al. Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med. 191:2000;275-286.
10. Miyamoto T., Ohneda O., Arai F., Iwamoto K., Okada S., Takagi K., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood. 98:2001;2544-2554.
11. Takai H., Kanematsu M., Yano K., Tsuda E., Higashio K., Ikeda K., et al. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem. 273:1998;27091-27096.
12. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ Nature. 408:2000;600-605.
13. Toraldo G., Roggia C., Qian W.P., Pacifici R., Weitzmann M.N. IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor κ B ligand and tumor necrosis factor α from T cells. Proc Natl Acad Sci USA. 100:2003;125-130.
14. Horwood N.J., Kartsogiannis V., Quinn J.M., Romas E., Martin T.J., Gillespie M.T. Activated T lymphocytes support osteoclast formation in vitro. Biochem Biophys Res Commun. 265:1999;144-150.
15. Kong Y.Y., Feige U., Sarosi I., Bolon B., Tafuri A., Morony S., et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature. 402:1999;304-309.
16. Kotake S., Udagawa N., Hakoda M., Mogi M., Yano K., Tsuda E., et al. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Arthritis Rheum. 44:2001;1003-1012.
17. Gravallese E.M., Manning C., Tsay A., Naito A., Pan C., Amento E., et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum. 43:2000;250-258.
18. Teng Y.T., Nguyen H., Gao X., Kong Y.Y., Gorczynski R.M., Singh B., et al. Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection. J Clin Invest. 106:2000;R59-67.
19. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behcet's disease. Lancet. 1:1989;1093-1096.
20. Pasero G., Priolo F., Marubini E., Fantini F., Ferraccioli G., Magaro M., et al. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A. Arthritis Rheum. 39:1996;1006-1015.
21. Clipstone N.A., Crabtree G.R. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 357:1992;695-697.
22. Mouzaki A., Rungger D. Properties of transcription factors regulating interleukin-2 gene transcription through the NFAT binding site in untreated or drug-treated naive and memory T-helper cells. Blood. 84:1994;2612-2621.
23. Tsuboi A., Muramatsu M., Tsutsumi A., Arai K., Arai N. Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-κ B/AP-1 in T cells. Biochem Biophys Res Commun. 199:1994;1064-1072.
24. Kubo M., Kincaid R.L., Ransom J.T. Activation of the interleukin-4 gene is controlled by the unique calcineurin-dependent transcriptional factor NF(P). J Biol Chem. 269:1994;19441-19446.
25. Campbell P.M., Pimm J., Ramassar V., Halloran P.F. Identification of a calcium-inducible, cyclosporine sensitive element in the IFN-γ promoter that is a potential NFAT binding site. Transplantation. 61:1996;933-939.
26. Epstein S., Shane E., Bilezikian J.P. Organ transplantation and osteoporosis. Curr Opin Rheumatol. 7:1995;255-261.
27. Sambrook P.N., Kelly P.J., Keogh A.M., Macdonald P., Spratt P., Freund J., et al. Bone loss after heart transplantation: a prospective study. J Heart Lung Transplant. 13:1994;116-120. discussion 121.
28. Thiebaud D., Krieg M.A., Gillard-Berguer D., Jacquet A.F., Goy J.J., Burckhardt P. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest. 26:1996;549-555.
29. Cvetkovic M., Mann G.N., Romero D.F., Liang X.G., Ma Y., Jee W.S., et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation. 57:1994;1231-1237.
30. Movsowitz C., Epstein S., Fallon M., Ismail F., Thomas S. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology. 123:1988;2571-2577.
31. Buchinsky F.J., Ma Y., Mann G.N., Rucinski B., Bryer H.P., Romero D.F., et al. T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology. 137:1996;2278-2285.
32. Ishida N., Hayashi K., Hoshijima M., Ogawa T., Koga S., Miyatake Y., et al. Large scale gene expression analysis of osteoclastogenesis in vitro and elucidation of NFAT2 as a key regulator. J Biol Chem. 277:2002;41147-41156.
33. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 3:2002;889-901.
34. Matsuzaki K., Katayama K., Takahashi Y., Nakamura I., Udagawa N., Tsurukai T., et al. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology. 140:1999;925-932.
35. Suda T., Jimi E., Nakamura I., Takahashi N. Role of 1 α,25-dihydroxyvitamin D3 in osteoclast differentiation and function. Methods Enzymol. 282:1997;223-235.
36. Owens J.M., Gallagher A.C., Chambers T.J. IL-10 modulates formation of osteoclasts in murine hemopoietic cultures. J Immunol. 157:1996;936-940.
37. Thirunavukkarasu K., Miles R.R., Halladay D.L., Yang X., Galvin R.J., Chandrasekhar S., et al. Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-β (TGF-β): mapping of the OPG promoter region that mediates TGF-β effects. J Biol Chem. 276:2001;36241-36250.
38. 3-stimulated osteoclast-like cell formation in vitro by a mechanism that is dependent on prostaglandin synthesis. J Immunol. 165:2000;4231-4238.
39. + T lymphocytes in osteoclast differentiation in vitro. Endocrinology. 137:1996;2457-2463.
40. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., et al. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J Immunol. 156:1996;4274-4279.
41. Horwood N.J., Udagawa N., Elliott J., Grail D., Okamura H., Kurimoto M., et al. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor. J Clin Invest. 101:1998;595-603.
42. Udagawa N., Horwood N.J., Elliott J., Mackay A., Owens J., Okamura H., et al. Interleukin-18 (interferon-γ-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-γ to inhibit osteoclast formation. J Exp Med. 185:1997;1005-1012.
43. Awumey E.M., Moonga B.S., Sodam B.R., Koval A.P., Adebanjo O.A., Kumegawa M., et al. Molecular and functional evidence for calcineurin-A α and β isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption. Biochem Biophys Res Commun. 254:1999;248-252.
44. 2+ accelerates nuclear translocation of NF-κB in osteoclasts. J Biol Chem. 278:2003;8286-8293.
45. Orcel P., Denne M.A., de Vernejoul M.C. Cyclosporin-A in vitro decreases bone resorption, osteoclast formation, and the fusion of cells of the monocyte-macrophage lineage. Endocrinology. 128:1991;1638-1646.
46. Sun L., Moonga B.S., Lu M., Zaidi N., Iqbal J., Blair H.C., et al. Molecular cloning, expression, and function of osteoclastic calcineurin Aα Am J Physiol Renal Physiol. 284:2003;F575-583.